Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Case: Evolving Stroke After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presenter: Julia Seeger

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

The Role of Cerebral Embolic Protection in TAVR

Presenter: Samir Kapadia

October 28, 2024

Presentation TCT 2024

PROTEMBO Case presentation from the EU

Presenter: Stephan Haussig

October 28, 2024

Presentation TCT 2024

Importance of DW-MRI in Cerebral Embolic Protection Trials

Presenter: Alexandra Lansky

October 28, 2024

Presentation TCT 2024

PROTEMBO Case presentation from the USA

Presenter: Joshua Rovin

October 28, 2024

Presentation TCT 2024

The PROTEMBO IDE Study – Novel Endpoint Design

Presenter: Ben Saville

October 28, 2024

Presentation TCT 2024

CEP Technology Landscape and Study Design

Presenter: Mathew Williams

October 28, 2024

Presentation TCT 2024

Contemporary Perspectives on Cerebral Injury in TAVR

Presenter: Michael Dwyer

October 28, 2024

Presentation TCT 2024

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

Presenter: Han Su Park

October 27, 2024

Advertisement

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Case: Evolving Stroke After TAVR

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

The Role of Cerebral Embolic Protection in TAVR

PROTEMBO Case presentation from the EU

Importance of DW-MRI in Cerebral Embolic Protection Trials

PROTEMBO Case presentation from the USA

The PROTEMBO IDE Study – Novel Endpoint Design

CEP Technology Landscape and Study Design

Contemporary Perspectives on Cerebral Injury in TAVR

Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry (Sentinel)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content